FDA Inspection 1167411 — Sharp Drugs, Inc.
The FDA completed an inspection of Sharp Drugs, Inc. on Apr 6, 2022 in Westhampton Beach, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 6, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Westhampton Beach, NY (United States)